• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Hong Kong listing of medical device to become a public tender condition

Hong Kong listing of medical device to become a public tender condition

Hong Kong listing of medical device
Monday, 26 September 2022 / Published in Medical Device, Medical Devices Listing in Hong Kong, News, NMPA Registration in China

Hong Kong listing of medical device to become a public tender condition

Hong Kong listing of medical device under the voluntary Medical Device Administrative Control System (MDACS) was launched since November 2004, and was implemented by the Hong Kong Medical Device Division (MDD) to raise awareness for public safety and prepare for future mandatory requirements.

The MDD announced new procurement requirements (pilot run) for the supply of certain medical devices to the Department of Health (DH), including Hong Kong public hospitals, with effect from October 1, 2022, onwards.

Scope

Under the pilot run, the following medical devices shall preferably be listed under the MDACS for procurement by the DH:

  • condoms of class II or above
  • lubricants of class II or above
  • blood glucose meter
  • blood glucose strip

In general, medical devices are separately grouped into four classes (class I to IV for general medical devices and class A to D for in vitro diagnostic medical devices) in Hong Kong with class D and class IV being the class with the highest risk, and class A and class I being the lowest. However, only class II to IV general medical devices and class B to D in vitro diagnostic medical devices can apply for Hong Kong listing.

Purpose

  • To enhance the customer protection for Department of Health (DH) as a buyer of medical devices
  • To ensure the safety, quality and performance of the medical devices procured and to ensure the availability of after-sale (post-market) support from suppliers
  • To strike a balance between value for money purchase while enhancing public safety
  • To raise public awareness of the importance of MD safety and pave way for the introduction of long-term statutory control

Procurement Requirements

  • Medical device being procured by the DH is preferably listed under the MDACS
  • Quotation: A preference will be given in the quotation for listed medical devices under the MDACS
    • If there are more the one lowest conforming offers offering the same price, preference will be given to the medical device offered which are listed under the MDACS.
  • Tender: A technical score will be given in the marking scheme for listed medical devices under the MDACS
    • In assessment criterion under the tender evaluation, marks will be given for medical devices offered which are preferably listed under the MDACS
  • If the proposed medical device is accepted by the Government, the Tenderer shall be bounded by such offer and shall be deemed to form part of the Contract.
  • Each particular medical device procurement may have different requirements hence tenderers shall refer to the tender documents for specific details.

Submissions to be provided by supplier for indicating the compliance of the desirable requirements

  • To indicate in the schedule of tender / quotation whether the Item(s) offered is listed under the MDACS
  • To provide the listing number and a valid copy of the certificate of listing under the MDACS.
    • The vetting and approval of an application for listing a device should normally be completed within 12 weeks following the submission of the application and all the required support information, including labelling samples.

China Greater Bay Area Pathway

According to the specific prerequisites of importing Hong Kong medical devices to the Greater Bay Area (GBA) via the expedited pathway, the product must be procured and already operating in the public hospitals in Hong Kong.

The introduction of the new procurement requirements in Hong Kong becomes increasingly important to manufacturers interested in the GBA pathway, and are encouraged to apply for Hong Kong listing as early as possible whilst the Hong Kong DH plans to extend its scope to cover more medical devices.

Further information

Read the announcement of the new procurement requirements here.

Cisema can support manufacturers as their local responsible person (LRP) with Hong Kong listing of medical device. If you would like to know more about Hong Kong listing or the GBA pathway, please contact us.

GET IN TOUCH

🌐 Send us your enquiry
📚 Request our whitepapers
📣 Sign up for our newsletter

What you can read next

CMDE Compares EU and China Risk Management
China Adjusts Import Control for Child Safety Seats and Alloy Wheels
Simplified Registration of Cosmetics

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • GB9706 standards for medical electrical equipment

    GB9706 standards for medical electrical equipment – implementation details clarified

    GB9706 standards are important reference guidel...
  • Microbial limits for non-sterile chemical drugs

    Microbial limits for non-sterile chemical drugs, API and excipients – new guidelines issued

    Microbial limits for non-sterile chemical drugs...
  • Medical Device Supplementary Notice Period

    China’s Medical Device Supplementary Notice Period reverts to a one-year period

    China’s Medical Device Supplementary Notice Per...
  • Dental adhesive products registration review guidelines

    Dental adhesive products registration review guidelines issued by the CMDE

    Dental adhesive products registration review gu...
  • China’s Toothpaste Supervision & Administration Regulation

    China’s New Toothpaste Supervision & Administration Regulation: A brief guide

    China’s Toothpaste Supervision & Administra...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP